IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...

Kenya is Among three African Countries that are set to participate in a medical trial by IAVI- a global research organisation ...

Commercial cattle farms in low-incidence bovine tuberculosis (TB) areas of England and Wales are being invited to participate ...

According to DOH, the BCG vaccine protects infants against tuberculosis. The letters B, C, and G stand for Bacillus ...

Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...

Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...

A new study found that some medications could have the unintended benefit of reducing dementia risk, while others could ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...